BMI1 and chronic myelogenous leukemia, BCR-ABL1 positive: The Polycomb gene BMI1 expression exerts a negative predictive impact on several hematological malignancies, such as acute and chronic myeloid leukemia (CML), myelofibrosis, and follicular lymphoma.